Abstract Well‐designed population‐based seroepidemiologic studies can be used to refine estimates of infection severity and transmission, and are therefore an important component of epidemic surveillance. However, the interpretation of the results of seroepidemiologic studies for SARS‐CoV‐2 has been hampered to date principally by heterogeneity in the quality of the reporting of the results of the study and a lack of standardized methods and reporting. We provide here the ROSES‐S: R ep o rting of S ero e pidemiologic studies— S ARS‐CoV‐2. This is an updated checklist of 22 items that should be included in the reporting of all SARS‐CoV‐2 seroepidemiologic studies, irrespective of study design.
All Keywords
【저자키워드】 Infectious diseases, SARS‐CoV‐2, Seroepidemiologic studies, emerging, 【초록키워드】 severity, Infection, Transmission, heterogeneity, SARS‐CoV‐2, Epidemic, Surveillance, Interpretation, Study design, estimate, lack, can be used, 【제목키워드】 SARS‐CoV‐2, World Health Organization,
【저자키워드】 Infectious diseases, SARS‐CoV‐2, Seroepidemiologic studies, emerging, 【초록키워드】 severity, Infection, Transmission, heterogeneity, SARS‐CoV‐2, Epidemic, Surveillance, Interpretation, Study design, estimate, lack, can be used, 【제목키워드】 SARS‐CoV‐2, World Health Organization,